Quabodepistat: Understanding Liver Function Impact

We are studying how Quabodepistat is processed in adults with reduced liver function versus those with normal liver function. This research may help improve treatment safety and effectiveness for individuals with liver conditions.

6-12 monthsSafety phase (I)HepatologyInfectious Diseases

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical Center Comac Medical Ltd.
Medical Center Comac Medical Ltd
Sofia, Bulgaria
Medical Center Comac Medical Ltd.
Medical Center Comac Medical Ltd
Sofia, Bulgaria
Sponsor: Otsuka Pharmaceutical Development & Commercialization Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.